Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine

JAAD Case Rep. 2023 Mar 8:35:122-125. doi: 10.1016/j.jdcr.2023.02.016. eCollection 2023 May.

Authors

Alaina J Kessler¹, Andrew Para², George W Niedt², Paula Klein¹

Affiliations

¹ Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: Anti-transcriptional intermediary factor-1γ; capecitabine; dermatomyositis; triple-negative breast cancer.

Publication types

Case Reports